| Literature DB >> 8880449 |
I T Jackson1, P P Callan, R A Forté.
Abstract
Maxillary ameloblastoma is a different entity from its mandibular counterpart. It is reported to behave more aggressively and have a poorer prognosis. Eleven maxillary ameloblastomas (three recurrent) are reported with a follow-up ranging from 1 month to 12 years with no recurrences. It is proposed that radical treatment of these tumours, with good reconstruction, can give satisfactory function and survival. To that end, the tumours have been classified as to their position in the maxilla and surgical resection related to this.Entities:
Mesh:
Year: 1996 PMID: 8880449 DOI: 10.1016/s1010-5182(96)80006-0
Source DB: PubMed Journal: J Craniomaxillofac Surg ISSN: 1010-5182 Impact factor: 2.078